“The prospect of an unelected board without adequate accountability being given powers to make recommendations on Medicare spending that are historically within the jurisdiction of members of Congress is irresponsible and would be devastating to the Medicare system,” stated David D. Teuscher, MD, President of AAOS. “The passage of H.R. 1190 is a victory for the patients we serve.”
“The AAOS recognizes the importance of lowering health care costs and is committed to providing quality care that is cost-effective, but is deeply concerned about the specific impact that IPAB-directed cuts would have on patient access to quality musculoskeletal care,” stated Thomas C. Barber, MD, Chair of the AAOS Council on Advocacy. “Such a policy limits congressional authority with little accountability and precludes meaningful opportunity for stakeholder input. Further, requiring the IPAB to achieve savings in one-year increments is simply not conducive to generating savings through long-term delivery reforms. We thank leaders in the House for their continued work to improve the Medicare system and urge the Senate to pass this legislation as soon as possible.”
Follow the AAOS Office of Government Relations on Twitter (www.twitter.com/AAOSAdvocacy).